^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HV-101

    i
    Other names: HV-101
    Associations

    News

    Trials
    Company:
    Hervor Therap, TCRCure
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    12d
    HV-101 for Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=1, Terminated, Hervor Therapeutics | N=18 --> 1 | Recruiting --> Terminated; Portfolio prioritization
    Enrollment change • Trial termination
    |
    cyclophosphamide • fludarabine IV • HV-101
    almost2years
    HV-101 for Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=18, Recruiting, Hervor Therapeutics | Phase classification: P1/2 --> P1
    Phase classification • Metastases
    |
    cyclophosphamide • HV-101
    over2years
    HV-101 for Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=18, Recruiting, Hervor Therapeutics
    New P1/2 trial • Metastases
    |
    cyclophosphamide • HV-101